{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:11:14Z","timestamp":1750824674221,"version":"3.41.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11926-017-0682-4","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T09:59:11Z","timestamp":1501149551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pulmonary Involvement in Systemic Vasculitis"],"prefix":"10.1007","volume":"19","author":[{"given":"Luis Felipe","family":"Flores-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidegger","family":"Mateos-Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natllely","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"682_CR2","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ, et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015;30(Suppl 1):i14\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"682_CR3","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","volume":"50","author":"S Fujimoto","year":"2011","unstructured":"Fujimoto S, Watts RA, Kobayashi S, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology. 2011;50:1916\u201320.","journal-title":"Rheumatology"},{"key":"682_CR4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI65292","volume":"123","author":"AJ Roth","year":"2013","unstructured":"Roth AJ, Ooi JD, Hess JJ, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013;123:1773\u201383.","journal-title":"J Clin Invest"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12026-015-8687-4","volume":"64","author":"YC Kim","year":"2016","unstructured":"Kim YC, Choi YS, Alam J, et al. Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice. Immunol Res. 2016;64:438\u201344.","journal-title":"Immunol Res"},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"R Kain","year":"2008","unstructured":"Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med. 2008;14:1088\u201396.","journal-title":"Nat Med"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214\u201323.","journal-title":"N Engl J Med"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.40034","volume":"69","author":"PA Merkel","year":"2017","unstructured":"\u2022 Merkel PA, Xie G, Monach PA, et al. Identification of functional and expression polymorphisms associated with risk for anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol. 2017;69:1054\u201366. A study which ratified the findings of the large European GWAS study (previous reference).","journal-title":"Arthritis Rheumatol"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","volume":"120","author":"DJ Ciavatta","year":"2010","unstructured":"Ciavatta DJ, Yang J, Preston GA, et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest. 2010;120:3209\u201319.","journal-title":"J Clin Invest"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2010.04154.x","volume":"161","author":"M Abdgawad","year":"2010","unstructured":"Abdgawad M, Gunnarsson L, Bengtsson AA, et al. Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression. Clin Exp Immunol. 2010;161:89\u201397.","journal-title":"Clin Exp Immunol"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","volume":"160","author":"A Komocsi","year":"2002","unstructured":"Komocsi A, Lamprecht P, Csernok E, et al. Peripheral blood and granuloma CD4(+)CD28(\u2212) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener\u2019s granulomatosis. Am J Pathol. 2002;160:1717\u201324.","journal-title":"Am J Pathol"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","volume":"6","author":"M Rimbert","year":"2011","unstructured":"Rimbert M, Hamidou M, Braudeau C, et al. Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One. 2011;6:e18734.","journal-title":"PLoS One"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.37959","volume":"65","author":"ME Free","year":"2013","unstructured":"Free ME, Bunch DO, McGregor JA, et al. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum. 2013;65:1922\u201333.","journal-title":"Arthritis Rheum"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"E2615","DOI":"10.1073\/pnas.1210147109","volume":"109","author":"JD Ooi","year":"2012","unstructured":"Ooi JD, Chang J, Hickey MJ, et al. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A. 2012;109:E2615\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2215\/CJN.03950412","volume":"8","author":"DO Bunch","year":"2013","unstructured":"Bunch DO, McGregor JG, Khandoobhai NB, et al. Decreased CD5(+) B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol. 2013;8:382\u201391.","journal-title":"Clin J Am Soc Nephrol"},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","volume":"1","author":"H Xiao","year":"2016","unstructured":"Xiao H, Hu P, Falk RJ, Jennette JC. Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis (Basel). 2016;1:205\u201315.","journal-title":"Kidney Dis (Basel)"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1136\/ard.2011.153890","volume":"70","author":"NJ Holden","year":"2011","unstructured":"Holden NJ, Williams JM, Morgan MD, et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann Rheum Dis. 2011;70:2229\u201333.","journal-title":"Ann Rheum Dis"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","volume":"153","author":"AJ Porges","year":"1994","unstructured":"Porges AJ, Redecha PB, Kimberly WT, et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol. 1994;153:1271\u201380.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"682_CR19","first-page":"i46","volume":"30","author":"U Sch\u00f6nermarck","year":"2015","unstructured":"Sch\u00f6nermarck U, Csernok E, Gross WL. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014. Nephrol Dial Transplant. 2015;30(Suppl 1):i46\u201352.","journal-title":"Nephrol Dial Transplant"},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1992.52","volume":"41","author":"BH Ewert","year":"1992","unstructured":"Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 1992;41:375\u201383.","journal-title":"Kidney Int"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","volume":"174","author":"MA Little","year":"2009","unstructured":"Little MA, Smyth L, Salama AD, et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol. 2009;174:1212\u201320.","journal-title":"Am J Pathol"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955\u201363.","journal-title":"J Clin Invest"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/rheumatology\/ken202","volume":"47","author":"A Mueller","year":"2008","unstructured":"Mueller A, Holl-Ulrich K, Lamprecht P, Gross WL. Germinal centre-like structures in Wegener\u2019s granuloma: the morphological basis for autoimmunity? Rheumatology. 2008;47:1111\u20133.","journal-title":"Rheumatology"},{"key":"682_CR24","doi-asserted-by":"crossref","unstructured":"Hu P, Xiao H, Alba MA, Falk RJ, Jennette JC. Anti-MPO antibodies cause granulomatosis in mice: an animal model of GPA. Rheumatology 2017;56 (suppl. 3):iii29. Abstract WS6_1. The 18th International Vasculitis & ANCA Workshop 2017.","DOI":"10.1093\/rheumatology\/kex120"},{"key":"682_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/kei217","volume":"45","author":"DR Thickett","year":"2006","unstructured":"Thickett DR, Richter AG, Nathani N, et al. Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Rheumatology. 2006;45:261\u20138.","journal-title":"Rheumatology"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/keq061","volume":"49","author":"V Ravindran","year":"2010","unstructured":"Ravindran V, Watts RA. Pulmonary haemorrhage in ANCA associated vasculitis. Rheumatology. 2010;49:1410\u20132.","journal-title":"Rheumatology"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/j.cpradiol.2014.01.002","volume":"43","author":"JP Lichtenberger","year":"2014","unstructured":"Lichtenberger JP, Digumarthy SR, Abbott GF, et al. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol. 2014;43:128\u201339.","journal-title":"Curr Probl Diagn Radiol"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.39475","volume":"68","author":"M Yamagata","year":"2016","unstructured":"\u2022\u2022 Yamagata M, Ikeda K, Tsushima K, et al. Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: a multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients. Arthritis Rheumatol. 2016;68:713\u201323. A very informative study concerning the detailed imagenological findings in MPA and their changes according to treatment.","journal-title":"Arthritis Rheumatol."},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/thx.2005.040287","volume":"60","author":"G Rolla","year":"2005","unstructured":"Rolla G, Heffler E, Guida G, et al. Exhaled NO in diffuse alveolar haemorrhage. Thorax. 2005;60:614\u20135.","journal-title":"Thorax"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.rdc.2015.01.004","volume":"41","author":"L Lally","year":"2015","unstructured":"Lally L, Spiera F. Pulmonary vasculitis. Rheum Dis Clin N Am. 2015;41:315\u201331.","journal-title":"Rheum Dis Clin N Am"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.chest.2016.09.002","volume":"151","author":"K Ussavarungsi","year":"2017","unstructured":"\u2022 Ussavarungsi K, Kern R, Anja C, et al. Transbronchial cryobiopsy in diffuse parenchymal lung disease: retrospective analysis of 74 cases. Chest. 2017;151:400\u20138. An article describing a recent technique to obtain adequate samples in diffuse lung parenchymal disease from different etiologies.","journal-title":"Chest"},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.rcl.2016.05.007","volume":"54","author":"S Mahmoud","year":"2016","unstructured":"Mahmoud S, Ghosh S, Farver C, et al. Pulmonary vasculitis: spectrum of imaging appearances. Radiol Clin N Am. 2016;54:1097\u2013118.","journal-title":"Radiol Clin N Am"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.sult.2012.05.001","volume":"33","author":"E Casta\u00f1er","year":"2012","unstructured":"Casta\u00f1er E, Alguersuari A, Andreu M, et al. Imaging findings in pulmonary vasculitis. Semin Ultrasound CT MR. 2012;33:567\u201379.","journal-title":"Semin Ultrasound CT MR"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12890-015-0068-1","volume":"15","author":"S Ikeda","year":"2015","unstructured":"\u2022 Ikeda S, Arita M, Misaki K, et al. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study. BMC Pulm Med. 2015;15:78. Important study from Japan in where many GPA patients are MPO-ANCA positive, and poses the question regarding clinical classification versus serotyping as a more accurate discrimination tool.","journal-title":"BMC Pulm Med"},{"key":"682_CR35","doi-asserted-by":"publisher","unstructured":"Alba MA, Flores-Su\u00e1rez LF, Henderson AG, et al. Interstitial lung disease in ANCA vasculitis. Autoimmun Rev. 2017; doi: 10.1016\/j.autrev.2017.05.008 .","DOI":"10.1016\/j.autrev.2017.05.008"},{"key":"682_CR36","doi-asserted-by":"crossref","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","volume":"2","author":"N Kagiyama","year":"2015","unstructured":"\u2022\u2022 Kagiyama N, Takayanagi N, Kanauchi T, et al. Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis. BMJ Open Resp Res. 2015;2:e000058. A relevant article which describes that some patients with IPF can evolve to MPA, and the influence of GC treatment (or not) in possibly evolving to that endpoint.","journal-title":"BMJ Open Resp Res"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","volume":"107","author":"M Ando","year":"2013","unstructured":"Ando M, Miyazaki E, Ishii T, et al. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013;107:608\u201315.","journal-title":"Respir Med"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10157-012-0710-7","volume":"17","author":"S Homma","year":"2013","unstructured":"Homma S, Suzuki A, Sato K. Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist. Clin Exp Nephrol. 2013;17:667\u201371.","journal-title":"Clin Exp Nephrol"},{"key":"682_CR39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"\u2022\u2022 Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. A series of 49 patients and review of the literature. Medicine. 2014;93:340\u20139. The largest up to date single center study regarding this complication in patients with AAV.","journal-title":"Medicine"},{"key":"682_CR40","doi-asserted-by":"publisher","unstructured":"\u2022 Iftikhar IH, Alghothani L, Sardi A, et al. Transbronchial lung cryobiopsy and video-assisted lung thorachoscopic lung biopsy in the diagnosis of diffuse parenchymal disease: e meta-analysis of diagnostic test accuracy. Ann Am Thorac Soc. 2017; doi: 10.1513\/AnnalsATS.201701-086SR . This metaanalysis secures the safety of transbronchial lung biopsies versus video-assisted thoracoscopic tissue obtainment, with similar diagnostic accuracy in diffuse lung diseases.","DOI":"10.1513\/AnnalsATS.201701-086SR"},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. New Engl J Med. 2013;369:417\u201327.","journal-title":"New Engl J Med"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.38788","volume":"66","author":"EM Miloslavsky","year":"2014","unstructured":"\u2022 Miloslavsky EM, Specks U, Merkel PA, et al. Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2014;66:3151\u20139. Retreatment with RTX in relapsing patients is safe and probably a better option than other treatments, in patients previously treated with CYC or RTX.","journal-title":"Arthritis Rheumatol."},{"key":"682_CR44","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.39562","volume":"68","author":"R Cartin-Ceba","year":"2016","unstructured":"\u2022\u2022 Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis. Predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol. 2016;68:1467\u201376. The most comprehensive up to date study of alveolar hemorrhage in the context of AAV. It details important points to be considered regarding outcome and therapy.","journal-title":"Arthritis Rheumatol."},{"key":"682_CR45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","volume":"71","author":"JU Holle","year":"2012","unstructured":"Holle JU, Dubrau C, Herlyn K, et al. Rituximab for refractury granulomatosis with polyangiitis (Wegener\u2019s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis. 2012;71:327\u201333.","journal-title":"Ann Rheum Dis"},{"key":"682_CR46","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K Groot de","year":"2005","unstructured":"de Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody associated-vasculitis. Arthritis Rheum. 2005;52:2461\u20139.","journal-title":"Arthritis Rheum"},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"\u2022\u2022 Guillevin L, Pagnoux C, Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371:1771\u201380. A seminal study regarding RTX treatment for remission maintenance in AAV as compared to the standard for this indication since 1993.","journal-title":"N Engl J Med"},{"key":"682_CR48","doi-asserted-by":"crossref","first-page":"i83","DOI":"10.1093\/ndt\/gfu385","volume":"30","author":"K Hirayama","year":"2015","unstructured":"Hirayama K, Kobayashi M, Usui J, et al. Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan. Nephrol Dial Transplant. 2015;30:i83\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1843.2004.00581.x","volume":"9","author":"S Homma","year":"2004","unstructured":"Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology. 2004;9:190\u20136.","journal-title":"Respirology"},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10067-015-2967-1","volume":"34","author":"LF Flores-Su\u00e1rez","year":"2015","unstructured":"Flores-Su\u00e1rez LF, Ruiz N, Saldarriaga Rivera LM, et al. Reduced survival in microscopic polyangiitis patients with pulmonary fibrosis in a respiratory center. Clin Rheumatol. 2015;34:1653\u20134.","journal-title":"Clin Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-017-0682-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-017-0682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:19:18Z","timestamp":1750789158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-017-0682-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s11926-017-0682-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"56"}}